-
microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res. 2010 Aug 30; Authors: Lin RJ, Lin YC, Chen J, Kuo HH, Chen YY, Diccianni MB, London WB, Chang CH, Yu AL Neuroblastoma (NB) is a common childhood tumor and accounts for 15...
-
Transcriptional Repression of SKP2 Is Impaired in MYCN-Amplified Neuroblastoma. Cancer Res. 2010 Apr 27; Authors: Muth D, Ghazaryan S, Eckerle I, Beckett E, Pöhler C, Batzler J, Beisel C, Gogolin S, Fischer M, Henrich KO, Ehemann V, Gillespie P, Schwab M, Westermann F The cell cycle regulator, SKP2...
-
Serial Transcriptome Analysis and Cross-Species Integration Identifies Centromere-Associated Protein E as a Novel Neuroblastoma Target. Cancer Res. 2010 Mar 16; Authors: Balamuth NJ, Wood A, Wang Q, Jagannathan J, Mayes P, Zhang Z, Chen Z, Rappaport E, Courtright J, Pawel B, Weber B, Wooster R, Sekyere...
-
Cyclin D1/Cyclin-Dependent Kinase 4 Interacts with Filamin A and Affects the Migration and Invasion Potential of *** Cancer Cells. Cancer Res. 2010 Feb 23; Authors: Zhong Z, Yeow WS, Zou C, Wassell R, Wang C, Pestell RG, Quong JN, Quong AA Cyclin D1 belongs to a family of proteins that regulate progression...
-
p53 Is a Direct Transcriptional Target of MYCN in Neuroblastoma. Cancer Res. 2010 Feb 9; Authors: Chen L, Iraci N, Gherardi S, Gamble LD, Wood KM, Perini G, Lunec J, Tweddle DA MYCN amplification occurs in approximately 25% of neuroblastomas, where it is associated with rapid tumor progression and poor...
-
NF-{kappa}B, and not MYCN, Regulates MHC Class I and Endoplasmic Reticulum Aminopeptidases in Human Neuroblastoma Cells. Cancer Res. 2010 Jan 26; Authors: Forloni M, Albini S, Limongi MZ, Cifaldi L, Boldrini R, Nicotra MR, Giannini G, Natali PG, Giacomini P, Fruci D Neuroblastoma (NB) is the most common...
-
Related Articles Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity. Cancer Res. 2009 Dec 15;69(24):9271-80 Authors: Kim Y, Lin Q, Zelterman D, Yun Z Reduced oxygenation, or hypoxia, inhibits differentiation and facilitates stem cell maintenance. Hypoxia commonly...
-
Related Articles Down-regulation of c-FLIP Enhances death of cancer cells by smac mimetic compound. Cancer Res. 2009 Oct 1;69(19):7729-38 Authors: Cheung HH, Mahoney DJ, Lacasse EC, Korneluk RG Smac mimetic compounds (SMC) are novel small molecules being developed for cancer therapy. The mechanism of...
-
Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients. Cancer Res. 2009 Sep 1; Authors: Passoni L, Longo L, Collini P, Coluccia AM, Bozzi F, Podda M, Gregorio A, Gambini C, Garaventa A, Pistoia V, Del Grosso F, Tonini GP, Cheng M, Gambacorti-Passerini...
-
Small-Molecule Multidrug Resistance-Associated Protein 1 Inhibitor Reversan Increases the Therapeutic Index of Chemotherapy in Mouse Models of Neuroblastoma. Cancer Res. 2009 Aug 4; Authors: Burkhart CA, Watt F, Murray J, Pajic M, Prokvolit A, Xue C, Flemming C, Smith J, Purmal A, Isachenko N, Komarov...
-
Related Articles MicroRNA miR-29 Modulates Expression of Immunoinhibitory Molecule B7-H3: Potential Implications for Immune Based Therapy of Human Solid Tumors. Cancer Res. 2009 Jul 7; Authors: Xu H, Cheung IY, Guo HF, Cheung NK B7-H3, a surface immunomodulatory glycoprotein, inhibits natural killer...